Study questions worth of ultrasound and removing benign ovarian cysts in preventing cancer
This article was originally published in Clinica
A 15-year study of over 5,000 women in the UK has shown for the first time that removing benign ovarian cysts does not reduce a woman's chance of dying from ovarian cancer. The study has also questioned the value of ultrasound as a cost-effective screening tool for the disease.
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.